- Home
- Products
- Customized FluoroAb™
- CTLA4
- Ticilimumab-iFluor 555
Ticilimumab-iFluor 555 (CAT#: ADC-FL-1050)
This product is comprised of an anti-CTLA4 monoclonal antibody (Ticilimumab) labeled with iFluor 555. iFluor 555 is a fluorescent dye and it's excitation/emission is 555/580 nm.
- TARGET
- ANTIBODY
- DYE
- Name
- CTLA4
- Alternative Names
- CTLA4; cytotoxic T-lymphocyte-associated protein 4; celiac disease 3 , CELIAC3; cytotoxic T-lymphocyte protein 4; CD; CD28; CD152; GSE; ICOS; CD152 isoform; celiac disease 3; cytotoxic T-lymphocyte antigen 4; cytotoxic T-lymphocyte-associated antigen 4; cytotoxic T-lymphocyte-associated serine esterase-4; cytotoxic T lymphocyte associated antigen 4 short spliced form; ligand and transmembrane spliced cytotoxic T lymphocyte associated antigen 4; GRD4; CTLA-4; IDDM12; CELIAC3;
- Overview
- This gene is a member of the immunoglobulin superfamily and encodes a protein which transmits an inhibitory signal to T cells. The protein contains a V domain, a transmembrane domain, and a cytoplasmic tail. Alternate transcriptional splice variants, encoding different isoforms, have been characterized. The membrane-bound isoform functions as a homodimer interconnected by a disulfide bond, while the soluble isoform functions as a monomer. Mutations in this gene have been associated with insulin-dependent diabetes mellitus, Graves disease, Hashimoto thyroiditis, celiac disease, systemic lupus erythematosus, thyroid-associated orbitopathy, and other autoimmune diseases.
- Overview
- Human Anti-CTLA4 IgG2 antibody, Ticilimumab
- Generic name
- Ticilimumab
- Species Reactivity
- Human
- Name
- iFluor 555
- Excitation⁄Emission (nm)
- 555/580
- Detection method
- Fluorescent
For Research Use Only. NOT FOR CLINICAL USE.
Related Products
- Anti-IGF2 MAb (Clone 1)-iFluor® 555 Succinimidyl Ester (CAT#: WJY0-LS15994)
- Altumomab-iFluor 647 (CAT#: ADC-FL-945)
- Anti-CSF2RA MAb (Clone 1)-iFluor® 350 Succinimidyl Ester (CAT#: WJY0-LS196)
- Anti-ITGAV+ITGB3 MAb (Clone 1)-iFluor® 405 Succinimidyl Ester (CAT#: WJY0-LS2287)
- Anti-CD19 MAb (Clone 20)-iFluor® 430 Succinimidyl Ester (CAT#: WJY0-LS4002)
- Anti-CSF2RA MAb (Clone 2)-iFluor® 350 Succinimidyl Ester (CAT#: WJY0-LS1234)
- Anti-CD79B MAb (Clone 11)-iFluor® 555 Succinimidyl Ester (CAT#: WJY0-LS15888)
- Anti-GD3 MAb (Clone 1)-iFluor® 460 Succinimidyl Ester (CAT#: WJY0-LS8421)
- Anti-APP MAb (Clone 21)-iFluor® 514 Succinimidyl Ester (CAT#: WJY0-LS11853)
- Anti-IL6R MAb (Clone 3)-iFluor® 514 Succinimidyl Ester (CAT#: WJY0-LS12124)
Published Data
+ Submit Publications
Scientific Resources
Customer Reviews and FAQs
There are currently no Customer reviews or questions for ADC-FL-1050. Click the button above to contact us or submit your feedback about this product.
Quick Links
Other Products
Same Target
| CAT# | Product Name | Linker | Payload |
| ADC-W-1002 | Anti-CTLA4 (Ipilimumab)-MC-Vc-PAB-SN38 ADC | MC-Vc-PAB (maleimidocaproyl-valine-citrulline-p-aminobenzoyloxycarbonyl) | SN-38 (7-ethyl-10-hydroxycamptothecin) |
| ADC-W-998 | Anti-CTLA4 (Ipilimumab)-SMCC-DM1 ADC | SMCC (N-succinimidyl 4-(Nmaleimidomethyl)cyclohexane-1-carboxylate) | DM1 (N2'-Deacetyl-N2'-(3-mercapto-1-oxopropyl)maytansine) |
| ADC-W-1008 | Anti-CTLA4 (Ticilimumab)-MC-Vc-PAB-SN38 ADC | MC-Vc-PAB (maleimidocaproyl-valine-citrulline-p-aminobenzoyloxycarbonyl) | SN-38 (7-ethyl-10-hydroxycamptothecin) |
| ADC-W-1004 | Anti-CTLA4 (Ticilimumab)-SMCC-DM1 ADC | SMCC (N-succinimidyl 4-(Nmaleimidomethyl)cyclohexane-1-carboxylate) | DM1 (N2'-Deacetyl-N2'-(3-mercapto-1-oxopropyl)maytansine) |
| ADC-W-1001 | Anti-CTLA4 (Ipilimumab)-MC-Vc-PAB-MMAE ADC | MC-Vc-PAB (maleimidocaproyl-valine-citrulline-p-aminobenzoyloxycarbonyl) | MMAE |
Online Inquiry
Welcome! For price inquiries, please feel free to contact us through the form on the left side. We will get back to you as soon as possible.
